Trichomoniasis

• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: Point of Care Diagnosis of Vaginal Infections [NA]

  Completed clinical trial evaluating a point-of-care diagnostic test for vaginal infections. Results have been posted for vaginitis, bacteria…

• FDA approval · 2026-02-13
  FDA Approved: METRONIDAZOLE — Original Application (Viona Pharmaceuticals Inc)

  FDA approved the original ANDA for metronidazole from Viona Pharmaceuticals Inc, enabling a generic version of the antibiotic to be marketed…

• CLINICAL_TRIALS research · 2025-12-31
  Clinical Trial Update: Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs [Phase 2]

  Phase 2 single-arm trial evaluating menstrual cups to reduce bacterial vaginosis and sexually transmitted infections among economically vuln…

• CLINICAL_TRIALS research · 2025-12-18
  Clinical Trial Update: Improving Maternal and Child Health Through Point-of-care STI Testing [NA]

  Emory University reports a clinical trial update on point-of-care testing for sexually transmitted infections to improve maternal and child …

• CLINICAL_TRIALS trial_result · 2025-09-25
  Clinical Trial Update: Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe [NA]

  This clinical trial update reports the completion of a study evaluating point-of-care diagnostics for sexually transmitted infections and an…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-07-30
  Clinical Trial Update: Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile) [NA]

  Completed clinical trial evaluating screening for sexually transmitted infections during pregnancy to prevent adverse birth and newborn outc…

• CLINICAL_TRIALS research · 2025-07-24
  Clinical Trial Update: Endosymbionts in Trichomonas Vaginalis Pathogenicity

  This clinical trial, sponsored by Medical University of Vienna, is investigating the role of endosymbionts in the pathogenicity of Trichomon…

• CLINICAL_TRIALS research · 2025-06-26
  Clinical Trial Update: Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision [NA]

  A clinical trial assessing the acceptability and feasibility of self-swab testing for sexually transmitted infections at the time of telemed…

• CLINICAL_TRIALS trial_result · 2025-06-06
  Clinical Trial Update: Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole [Phase 4]

  A Phase 4 clinical trial is comparing metronidazole and secnidazole for Trichomonas vaginalis infection, with recruitment ongoing and inclus…

• CLINICAL_TRIALS trial_result · 2025-05-13
  Clinical Trial Update: Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions

  A clinical trial evaluating a rapid microscopic diagnostic system for detecting various vaginitis conditions has completed, assessing its pe…

• FDA approval · 2025-02-14
  FDA Approved: METRONIDAZOLE — Supplemental Application (Alembic Pharmaceuticals Limited)

  FDA approved a supplemental application for metronidazole from Alembic Pharmaceuticals Limited.

• FDA approval · 2024-12-17
  FDA Approved: METRONIDAZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for Metronidazole from Sun Pharmaceutical Industries, Inc., resulting in continued approval of this …

• FDA approval · 2024-10-25
  FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. under an ANDA.

• FDA approval · 2024-10-25
  FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for Metronidazole filed by Aurobindo Pharma Limited, authorizing the generic product under the suppl…

• FDA approval · 2024-10-25
  FDA Approved: METRONIDAZOLE — Supplemental Application (Alembic Pharmaceuticals Limited)

  FDA approves a supplemental application for Metronidazole from Alembic Pharmaceuticals Limited, confirming continued approval of the generic…

• CLINICAL_TRIALS research · 2024-08-26
  Clinical Trial Update: Acceptability Research on Integrated Point of Care Sexually Transmitted Infection (STI) Testing and Expedited Partner Therapy (EPT)

  An acceptability study evaluating integrated point-of-care STI testing with expedited partner therapy (EPT) to improve testing and partner m…

• CLINICAL_TRIALS trial_result · 2024-08-26
  Clinical Trial Update: Point of Care Rapid STI Test Optimization and Validation Extension

  A completed trial update on optimizing and validating a point-of-care rapid STI test. The study targets detection of Chlamydia trachomatis i…

• FDA approval · 2024-06-18
  FDA Approved: METRONIDAZOLE — Supplemental Application (Alembic Pharmaceuticals Limited)

  FDA approved a supplemental application for Metronidazole from Alembic Pharmaceuticals Limited, granting approval for a generic version of t…

• FDA approval · 2024-06-18
  FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  The FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.) to modify…

• CLINICAL_TRIALS research · 2024-06-11
  Clinical Trial Update: Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis [NA]

  This clinical trial update outlines two oral tinidazole regimens being studied for safety and efficacy in refractory Trichomonas vaginalis i…

• FDA approval · 2024-01-09
  FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for Metronidazole from Aurobindo Pharma Limited.

• FDA label_change · 2023-11-22
  FDA Approved: METRONIDAZOLE — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for metronidazole from Prasco Laboratories, indicating an updated labeling/approval for an additiona…

• FDA approval · 2023-10-17
  FDA Approved: METRONIDAZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for Metronidazole filed by Sun Pharmaceutical Industries, Inc., updating the drug’s labeling as …

• CLINICAL_TRIALS trial_result · 2023-10-04
  Clinical Trial Update: A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis [Phase 3]

  Phase 3 study of Solosec for treatment of trichomoniasis completed with results posted.

• FDA approval · 2023-09-12
  FDA Approved: TINDAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)

  FDA approved a supplemental application for TINDAZOLE (tinidazole) from Rising Pharma Holdings, Inc., granting additional regulatory authori…